A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
about
Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitisTranslation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaireComparison of performance of the Assessment of SpondyloArthritis International Society, the European Spondyloarthropathy Study Group and the modified New York criteria in a cohort of Chinese patients with spondyloarthritisDevelopment of the ASQoL: a quality of life instrument specific to ankylosing spondylitisPrevalence, clinical relevance and characterization of circulating cytotoxic CD4+CD28- T cells in ankylosing spondylitisCirculating cytotoxic CD8(+) CD28(-) T cells in ankylosing spondylitisClinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximabTumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?Clinical Tools to Assess and Monitor SpondyloarthritisPatient-reported physical activity questionnaires: a systematic review of content and formatPhysical activity assessment in patients with axial spondyloarthritis compared to healthy controls: a technology-based approachDetection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonographyDepression in patients with SAPHO syndrome and its relationship with brain activity and connectivityA comprehensive systematic review of the development process of 104 patient-reported outcomes (PROs) for physical activity in chronically ill and elderly peopleWhole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis.Internet-based randomised controlled trials for the evaluation of complementary and alternative medicines: probiotics in spondyloarthropathyMonosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study.Ankylosing spondylitis in iran; late diagnosis and its causes.Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritisEvaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis.Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patientsHigher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis.Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.Frequency and characteristics of disease flares in ankylosing spondylitis.Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis.Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice.Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordiiEffectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy.Identification of RGS1 as a candidate biomarker for undifferentiated spondylarthritis by genome-wide expression profiling and real-time polymerase chain reaction.Normative values for the Bath Ankylosing Spondylitis Functional Index in the general population compared with ankylosing spondylitis patients in Morocco.Combined home exercise is more effective than range-of-motion home exercise in patients with ankylosing spondylitis: a randomized controlled trial.Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot studyEtanercept in the treatment of ankylosing spondylitis: A systematic review and meta-analysis.Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis.Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis.Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.
P2860
Q21195369-D1D526FB-C3A4-44EA-812E-AB7AA6D9CD89Q21245615-31A17F59-215F-40C2-BF64-2150B8E668F1Q24604766-F5497A50-1713-4F69-B0D6-6BB78B6051B1Q24674389-09B94FDA-61B8-4430-A863-84EEAD7CC458Q24797697-A503B250-33C1-482F-9C72-9DBBA0B0EF9EQ24800177-8E725FFF-697A-4F3C-BF8B-46FF696426E8Q24816557-A4395451-F436-4CB2-9ED6-438A6668A8EDQ24816905-3341E153-72AB-4728-9CA2-A012ADA7711CQ26777908-9C2768D2-1B3D-411D-A9A7-7B346FA8A3EEQ26866120-4D949944-B993-4847-BBD0-2298E35B44E7Q27008283-858FB2BA-994F-4593-920A-A4B8EB6979CFQ28396710-E0AA5EE3-0933-4CD6-89CE-AFC363F2CE6AQ28660749-2EDB72DD-D253-44BC-BE6C-2AF7924C9C0CQ30355621-AD9B7DF5-DACF-469D-A80F-D8E0DDC00924Q30511959-2588CB2C-BB5D-46B4-93A3-E708481AF0CCQ33275865-8393F293-881C-41BA-AC3D-52E9C6E0D036Q33314436-AB9016A7-9630-48A9-B483-DA26569EE695Q33630612-50919287-62AE-457F-B939-64E003382236Q33640595-358E5347-7D47-4EB3-9FBA-DC3A6822A09BQ33646340-8DB16A04-F034-414F-BA30-C51230C55296Q33661893-8514313E-9EBA-480F-A71A-4771CDCE9B4DQ33673930-D8726115-9EFE-441F-B007-6B9DA9D6EEACQ33684694-7FE964A5-6FCC-4CB5-BCE5-B319C61533FCQ33740351-809B4F7D-02E3-4AFC-8DF3-90606B3016BFQ33766318-1CB27732-36CD-484B-940C-ED99E54B2052Q33767110-2DB00B6E-898D-4D23-A318-9635F7F18FCFQ33785622-4C9B6602-AE32-4483-91E9-4318B2C91EDEQ33883662-40AFF2C8-F88F-4014-9B5E-4656C245F9B5Q33923298-630FFD0F-585B-43AB-91DB-FDFF0A1DC01CQ33993099-B2A96C3E-112A-4712-BC3F-2703EA82A4EDQ34014598-B286E359-51B6-462E-8691-78EE5EDBCF46Q34027624-BC93EDB5-2249-4E38-AAA9-20E045D90298Q34117039-CDDADA77-DDAB-46E1-977D-5FB40FF0A972Q34205061-60C87DFB-85DA-4C27-AACD-F7BB8A10F1A7Q34222218-C92A0FD9-76A7-470C-9FC4-096225473776Q34277511-847F32B1-3F31-47EC-9AA1-F5265CED2A4BQ34292245-700EFB9F-465D-4CCE-8650-59195FF60E0CQ34413304-19F50D29-9ED6-4A61-8A69-F80A0C0A6AC2Q34425497-6E6BD85E-8F9C-4911-B909-C814B065D80CQ34449888-1E1CA51B-FF1B-45E0-B3BB-FFBF66E15E42
P2860
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
A new approach to defining fun ...... Spondylitis Functional Index.
@ast
A new approach to defining fun ...... Spondylitis Functional Index.
@de
A new approach to defining fun ...... Spondylitis Functional Index.
@en
A new approach to defining fun ...... Spondylitis Functional Index.
@fr
A new approach to defining fun ...... Spondylitis Functional Index.
@nl
type
label
A new approach to defining fun ...... Spondylitis Functional Index.
@ast
A new approach to defining fun ...... Spondylitis Functional Index.
@de
A new approach to defining fun ...... Spondylitis Functional Index.
@en
A new approach to defining fun ...... Spondylitis Functional Index.
@fr
A new approach to defining fun ...... Spondylitis Functional Index.
@nl
prefLabel
A new approach to defining fun ...... Spondylitis Functional Index.
@ast
A new approach to defining fun ...... Spondylitis Functional Index.
@de
A new approach to defining fun ...... Spondylitis Functional Index.
@en
A new approach to defining fun ...... Spondylitis Functional Index.
@fr
A new approach to defining fun ...... Spondylitis Functional Index.
@nl
P2093
P1476
A new approach to defining fun ...... Spondylitis Functional Index.
@en
P2093
Jenkinson T
Kennedy LG
Mallorie P
Whitelock H
P304
P407
P577
1994-12-01T00:00:00Z